BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 36443295)

  • 21. SWI/SNF-deficient head and neck neoplasms: An overview.
    Agaimy A; Bishop JA
    Semin Diagn Pathol; 2021 May; 38(3):175-182. PubMed ID: 33663878
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Atypical teratoid/rhabdoid tumors (ATRTs) with SMARCA4 mutation are molecularly distinct from SMARCB1-deficient cases.
    Holdhof D; Johann PD; Spohn M; Bockmayr M; Safaei S; Joshi P; Masliah-Planchon J; Ho B; Andrianteranagna M; Bourdeaut F; Huang A; Kool M; Upadhyaya SA; Bendel AE; Indenbirken D; Foulkes WD; Bush JW; Creytens D; Kordes U; Frühwald MC; Hasselblatt M; Schüller U
    Acta Neuropathol; 2021 Feb; 141(2):291-301. PubMed ID: 33331994
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Poorly differentiated sinonasal tract malignancies: A review focusing on recently described entities.
    Agaimy A
    Cesk Patol; 2016; 52(3):146-53. PubMed ID: 27526015
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Sinonasal neoplasms: Update from the WHO 2022].
    Agaimy A
    Pathologie (Heidelb); 2023 Jul; 44(4):233-239. PubMed ID: 37286851
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cellular context determines DNA methylation profiles in SWI/SNF-deficient cancers of the gynecologic tract.
    Kommoss FK; Tessier-Cloutier B; Witkowski L; Forgo E; Koelsche C; Köbel M; Foulkes WD; Lee CH; Kolin DL; von Deimling A; Howitt BE
    J Pathol; 2022 Jun; 257(2):140-145. PubMed ID: 35218556
    [TBL] [Abstract][Full Text] [Related]  

  • 26. SMARCB1/INI1-deficient sinonasal carcinoma shows methylation of RASSF1 gene: A clinicopathological, immunohistochemical and molecular genetic study of a recently described entity.
    Laco J; Chmelařová M; Vošmiková H; Sieglová K; Bubancová I; Dundr P; Němejcová K; Michálek J; Čelakovský P; Mottl R; Sirák I; Vošmik M; Ryška A
    Pathol Res Pract; 2017 Feb; 213(2):133-142. PubMed ID: 28069272
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Loss of
    Chitguppi C; Rabinowitz MR; Johnson J; Bar-Ad V; Fastenberg JH; Molligan J; Berman E; Nyquist GG; Rosen MR; Evans JE; Mardekian SK
    J Neurol Surg B Skull Base; 2020 Dec; 81(6):610-619. PubMed ID: 33381364
    [No Abstract]   [Full Text] [Related]  

  • 28. Sinonasal undifferentiated carcinoma: clinicopathological spectrums and diagnosis reappraisal.
    Vaziri Fard E; Zhang S; Cai Z; Ding J; Sun Q; Saluja K; Zhu H
    Hum Pathol; 2019 Jul; 89():62-70. PubMed ID: 31054892
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High-grade sinonasal carcinomas and surveillance of differential expression in immune related transcriptome.
    Bell D; Bell A; Ferrarotto R; Glisson B; Takahashi Y; Fuller G; Weber R; Hanna E
    Ann Diagn Pathol; 2020 Dec; 49():151622. PubMed ID: 32927372
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunohistochemical Detection and Molecular Characterization of IDH-mutant Sinonasal Undifferentiated Carcinomas.
    Mito JK; Bishop JA; Sadow PM; Stelow EB; Faquin WC; Mills SE; Krane JF; French CA; Fletcher CDM; Hornick JL; Sholl LM; Jo VY
    Am J Surg Pathol; 2018 Aug; 42(8):1067-1075. PubMed ID: 29683816
    [TBL] [Abstract][Full Text] [Related]  

  • 31. SMARCA4-deficient rhabdoid tumours show intermediate molecular features between SMARCB1-deficient rhabdoid tumours and small cell carcinomas of the ovary, hypercalcaemic type.
    Andrianteranagna M; Cyrta J; Masliah-Planchon J; Nemes K; Corsia A; Leruste A; Holdhof D; Kordes U; Orbach D; Corradini N; Entz-Werle N; Pierron G; Castex MP; Brouchet A; Weingertner N; Ranchère D; Fréneaux P; Delattre O; Bush J; Leary A; Frühwald MC; Schüller U; Servant N; Bourdeaut F
    J Pathol; 2021 Sep; 255(1):1-15. PubMed ID: 33999421
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Loss of expression of SMARCA4 (BRG1), SMARCA2 (BRM) and SMARCB1 (INI1) in undifferentiated carcinoma of the endometrium is not uncommon and is not always associated with rhabdoid morphology.
    Ramalingam P; Croce S; McCluggage WG
    Histopathology; 2017 Feb; 70(3):359-366. PubMed ID: 27656868
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sinonasal undifferentiated carcinoma: clinical and pathologic features and a discussion on classification, cellular differentiation, and differential diagnosis.
    Ejaz A; Wenig BM
    Adv Anat Pathol; 2005 May; 12(3):134-43. PubMed ID: 15900114
    [TBL] [Abstract][Full Text] [Related]  

  • 34. SMARCB1 (INI-1)-Deficient Adenocarcinoma of the Sinonasal Tract: A Potentially Under-Recognized form of Sinonasal Adenocarcinoma with Occasional Yolk Sac Tumor-Like Features.
    Shah AA; Jain D; Ababneh E; Agaimy A; Hoschar AP; Griffith CC; Magliocca KR; Wenig BM; Rooper LM; Bishop JA
    Head Neck Pathol; 2020 Jun; 14(2):465-472. PubMed ID: 31468350
    [TBL] [Abstract][Full Text] [Related]  

  • 35. ARID1A, BRG1, and INI1 deficiency in undifferentiated and dedifferentiated endometrial carcinoma: a clinicopathologic, immunohistochemical, and next-generation sequencing analysis of a case series from a single institution.
    Korentzelos D; Elishaev E; Zhao C; Jones MW; Soong TR; Lesnock J; Orellana T; Zeccola A; Diamantopoulos LN; Wald AI; Bhargava R
    Hum Pathol; 2022 Dec; 130():65-78. PubMed ID: 36252860
    [TBL] [Abstract][Full Text] [Related]  

  • 36. SMARCB1 (INI-1)-deficient carcinomas of the sinonasal tract.
    Bishop JA; Antonescu CR; Westra WH
    Am J Surg Pathol; 2014 Sep; 38(9):1282-9. PubMed ID: 25007146
    [TBL] [Abstract][Full Text] [Related]  

  • 37. SWI/SNF-deficient malignancies of the female genital tract.
    McCluggage WG; Stewart CJR
    Semin Diagn Pathol; 2021 May; 38(3):199-211. PubMed ID: 32978032
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of novel diagnostic markers for sinonasal undifferentiated carcinoma.
    Takahashi Y; Gleber-Netto FO; Bell D; Roberts D; Xie TX; Abdelmeguid AS; Pickering C; Myers JN; Hanna EY
    Head Neck; 2019 Aug; 41(8):2688-2695. PubMed ID: 30932264
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sex determining region Y-box 2 (SOX2) amplification is an independent indicator of disease recurrence in sinonasal cancer.
    Schröck A; Göke F; Wagner P; Bode M; Franzen A; Braun M; Huss S; Agaimy A; Ihrler S; Menon R; Kirsten R; Kristiansen G; Bootz F; Lengerke C; Perner S
    PLoS One; 2013; 8(3):e59201. PubMed ID: 23544055
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Update on genetically defined lung neoplasms: NUT carcinoma and thoracic SMARCA4-deficient undifferentiated tumors.
    Chatzopoulos K; Boland JM
    Virchows Arch; 2021 Jan; 478(1):21-30. PubMed ID: 33409598
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.